Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
Stopped early · Not applicable · Has a placebo group
Conditions studied: Postmenopausal Syndrome
In brief
Estrogen and progesterone are two main female sex hormones. When a woman goes through menopause, the body's production of estrogen and progesterone significantly decreases. Recent studies have shown that the breakdown of fatty acids in cardiac muscle is important in maintaining a healthy heart, and that estrogen may enhance this process. Also, cardiovascular disease (CVD) occurs more frequently in postmenopausal women than in premenopausal women. This study will determine in postmenopausal women whether estrogen increases the heart's ability to use fats as energy and whether progesterone decreases this effect.
Key facts
- Study ID
- NCT00565916
- Run by
- Washington University School of Medicine
- People needed
- 22
- Starts
- 2004-08-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2018-10-16
Who can join
Age: 55 and older, up to 75. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy postmenopausal woman
- Body mass index less than 30
- Practices normal eating habits
- Stops hormone replacement therapy at least 6 months prior to study entry
You may not qualify if…
- Currently taking hormone replacement therapy
- History of cardiovascular disease
- Family history of coronary artery disease
- Recent history of smoking, high blood pressure, or hyperlipidemia
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.